Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis. [electronic resource] by
- Gandhi, Leena
- McNamara, Kate L
- Li, Danan
- Borgman, Christa L
- McDermott, Ultan
- Brandstetter, Kathleyn A
- Padera, Robert F
- Chirieac, Lucian R
- Settleman, Jeffrey E
- Wong, Kwok-Kin
Producer: 20090623
In:
Cancer prevention research (Philadelphia, Pa.) vol. 2
Availability: No items available.
|
|
7.
|
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity. [electronic resource] by
- Marcar, Lynnette
- Bardhan, Kankana
- Gheorghiu, Liliana
- Dinkelborg, Patrick
- Pfäffle, Heike
- Liu, Qi
- Wang, Meng
- Piotrowska, Zofia
- Sequist, Lecia V
- Borgmann, Kerstin
- Settleman, Jeffrey E
- Engelman, Jeffrey A
- Hata, Aaron N
- Willers, Henning
Producer: 20200713
In:
Cell reports vol. 27
Availability: No items available.
|
|
8.
|
A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer. [electronic resource] by
- Goldberg, Sarah B
- Supko, Jeffrey G
- Neal, Joel W
- Muzikansky, Alona
- Digumarthy, Subba
- Fidias, Panos
- Temel, Jennifer S
- Heist, Rebecca S
- Shaw, Alice T
- McCarthy, Patricia O
- Lynch, Thomas J
- Sharma, Sreenath
- Settleman, Jeffrey E
- Sequist, Lecia V
Producer: 20130214
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7
Availability: No items available.
|